CLINICAL_TRIALS
trial_result
· 2011-03-30
Clinical Trial Update: Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus [Phase 1]
Summary
A Phase 1 study evaluating two oral formulations of LX4211 in adults with Type 2 Diabetes Mellitus. The trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED